FI  Euclidean Capital




     Office Locations:

160 5th Ave. #9
New York, NY 10010

 

Stages:

  • Early
  • Late
  • Middle Market


 

Industries:

  • Financial Services
  • Food & Agriculture
  • Life Sciences & Healthcare

  •  

    Description:

    Euclidean Capital is the family office for hedge fund billionaire James Simons. There is very little public information available on Euclidean. The firm is believed to be focused mostly on individual stocks, with a preference for biotech. Euclidean also invests in Life Sciences and Financial Services startups. Simons worked as a National Security Agency codebreaker, founded Stony Brook University's math department, won an Oswald Veblen Prize for his work as a geometrician and co-authored the Chern-Simons Theory, a building block for string theory. According to Forbes, Simons net worth exceeds $28 billion. The Simons Foundation supports basic and discovery-driven science, and the Simon's Flatiron Institute bankrolls computational research in astrophysics, biology, mathematics, neuroscience, and quantum physics.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Ashvin Chhabra President & Chief Investment Officer
    James Simons Founder
    Monique Miller Head of Investment Strategy
    Uche Abalogu CTO

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/25/2024


      FundGuard


      NY


      $100,000,000


      Series C


      02/29/2024


      Kenai Therapeutics


      CA


      $82,000,000


      Series A


      02/08/2024


      Neurona Therapeutics


      CA


      $120,000,000


      Venture


      01/24/2024


      Sion Power


      AZ


      $75,000,000


      Series A


     

    Portfolio companies include:

     

    Recent News: